Glaxosmithkline Pharmaceuticals Ltd

BSE Code 500660	ISIN Demat INE159A01016	Book Value (₹) 115.06	NSE Symbol GLAXO	Div & Yield % 1.94	Market Cap (₹ Cr.) 47,153.32	P/E * 50.22	EPS * 55.42	Face Value (₹) 10

* Profit to Earning Ratio

* Earning Per Share

Stock Price Details
Last Price (₹)	2,748.15
Change	35.30 (1.28%)
Best Buy (₹)	0.00
Best Sell (₹)	0.00
Today's Range	2,748.15 - 2,813.35
52-Week Range	1,924.30 - 3,515.95
Beta (1 Year)	0.67

Chart

1 Day | 5 Day | 3 Month | 1 Year | 5 Year

Corporate Announcements
Glaxosmithkline Pharmaceuticals Ltd - Disclosure Under Regulation 30
Glaxosmithkline Pharmaceuticals Ltd - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Glaxosmithkline Pharmaceuticals Ltd - GlaxoSmithKline Pharmaceuticals Limited - Press Release
Glaxosmithkline Pharmaceuticals Ltd - GlaxoSmithKline Pharmaceuticals Limited - Press Release
Glaxosmithkline Pharmaceuticals Ltd - GlaxoSmithKline Pharmaceuticals Limited - Analysts/Institutional Investor Meet/Con. Call Updates
Glaxosmithkline Pharmaceuticals Ltd - GlaxoSmithKline Pharmaceuticals Limited - Analysts/Institutional Investor Meet/Con. Call Updates
Glaxosmithkline Pharmaceuticals Ltd - GlaxoSmithKline Pharmaceuticals Limited - News Verification
Glaxosmithkline Pharmaceuticals Ltd - Disclosure Under Regulation 30
Glaxosmithkline Pharmaceuticals Ltd - GlaxoSmithKline Pharmaceuticals Limited - Other General Purpose
Glaxosmithkline Pharmaceuticals Ltd - Rumour verification - Regulation 30(11)

Corporate Details
Incorporation Year : 1924
Chairman : Renu S Karnad
Ownership Group : MNC Asc-Glaxo
Sector : Pharmaceuticals
Industry : Pharmaceuticals - Multinational
Registered Office : Glaxosmithkline Pharmaceuticals Ltd GSK House, Dr Annie Besant Road Worli, Mumbai, Maharashtra - 400030, Phone : 91-022-24959595, Fax : 91-022-24959494
E-Mail : askus@gsk.com; ajay.a.nadkarni@gsk.com
URL : http://www.gsk-india.com

Investor Returns
Period	Date	Price	Returns (%)
1Week	22-Aug-2025	2,799.50	-0.57
1Month	29-Jul-2025	3,144.35	-11.48
3Month	29-May-2025	3,269.05	-14.85
6Month	28-Feb-2025	2,474.55	12.48
1Year	29-Aug-2024	2,769.40	0.51

Mutual Funds Holding
Scheme Name	% Holding	Market Value
SBI Midcap Fund	1.91	430.57
Kotak Large & Midcap Fund	1.24	347.89
Nippon India Pharma Fund	3.31	288.82
Nippon India Growth Mid Cap ..	0.46	176.79
Aditya Birla SL ELSS Tax Sav..	1.09	168.35

Peerset : Pharmaceuticals - Multinational

Company	Last Price (₹)	Change (%)	52Week High (₹)	52Week Low (₹)	Market Cap (₹ Cr.)
Abbott India Ltd	31,497.70	0.02	35,921.55	25,260.20	66,932.61
Pfizer Ltd	5,151.60	-0.40	6,452.85	3,742.90	23,567.40
Astrazeneca Pharma India Ltd	8,469.45	1.76	10,653.05	6,222.35	21,173.63
Sanofi Consumer Healthcare India Ltd	5,180.10	1.62	5,954.00	4,360.30	11,930.09
Sanofi India Ltd	5,139.05	0.52	7,593.60	4,145.90	11,835.23

Index Details

BSE 500, BSE 200, BSE HC, BSE DOLLEX, BSE Midcap

Attention Investors

Viewing your collateral data on Exchange Clearing Corporation websites

This is with reference to circular issued by NSE Clearing Ltd {NCL} ,Multi Commodity Exchange Clearing Corporation Limited {MCXCCL} ,National Commodity Clearing Limited {NCCL} and Indian Clearing Corporation Limited { ICCL} to provide visibility of client-wise collateral at all level, viz. TM, CM, and clearing corporation (CC), a reporting mechanism, covering both cash and non-cash collaterals.

Thus, in order to view collateral details, Exchange Clearing Corporation has provided a link for registration and viewing the collateral data on their websites, details are as follows:

NSE Clearing Ltd. (NCL) : NSCCL>Resources> Client collateral details> Web portal facility to clients https://investorhelpline.nseindia.com/ClientCollateral/welcomeCLUser Multi Commodity Exchange Clearing Corporation Limited (MCXCCL): MCXCCL>Client Reports https://clientreports.mcxccl.com/ National Commodity Clearing Limited (NCCL) : NCCL > Investors > Collateral verification https://ncdex.com/subscriber/login Indian Clearing Corporation Limited : https://www.icclindia.com/DynamicPages/UCCDetails.aspx

Clients are requested to ensure that their email address and mobile number as updated our records, same to be used as it shall be validated at the time of user registration to view the collateral details.

We believe that an educated investor is a protected investor.

Voluntary freezing/blocking the online access of the trading account

SEBI vide it’s circular SEBI/HO/MIRSD/POD-1/P/CIR/2024/4 dated January 12, 2024 and all Exchanges vide their circulars have mandated members to provide the facility of voluntary freezing/blocking the online access of the trading account to their clients on account of suspicious activities.

We are happy to inform you, that you can now voluntary freeze/block online access of your trading account in case you observe any suspicious activities by following these options:

Send an E-mail ID to stoptrade@systematixgroup.in. or
Call at 022-67048640 / 40874040

In effect to the above request, your online access will be disabled for your account and all pending orders, if any, shall be cancelled. However, fund transfers and withdrawals if any will be allowed

To unfreeze your account, you can contact us at 022-67048640 / 40874040, after carrying out necessary due diligence including validating your request and unfreeze unblock online access of your trading account.

Risk Disclosures on Derivatives

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28%of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: 1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

Precautions to be taken by clients while trading in derivatives / options and avoid practices such as :

Sharing of trading credentials : login id & passwords including OTP’s.
Trading in leveraged products like options without proper understanding, could lead to losses.
Writing/ selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
Trading in “Options” based on recommendations from unauthorised / unregistered investment advisors and influencers.
Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, calls, etc.

Issued in in the interest of investors, by Regulators

KYC is one-time exercise while dealing in securities markets. Once KYC is done through a SEBI registered intermediary (Broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary. - issued in the interest of investors.
No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as money remains in investor's account.
Prevent unauthorised transactions in your demat account → Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day - issued in the interest of investors.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.
SCORES: Filing of complaints on SCORES – Easy & quick - a) Register on SCORES portal b) Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, Email ID c) Benefits: i. Effective communication ii. Speedy redressal of the grievances EXCHANGES: Prevent Unauthorised transactions in your account → Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day.

Investor Grievances Escalation Matrix

Details of	Contact Person	Address	Contact No.	Email ID	Working Hours
Client Servicing	Kirti Surve	No. 303 304, 3rd Floor, Hallmark Business Plaza, Sant Dnyaneshwar Marg, Nr.Gurunanak Hospital, Bandra (E), Mumbai - 400051	022-67048675	qcsc@systematixgroup.in	Monday - Friday 09:00 AM to 06:00 PM
Head of Client Servicing	Ameya Borkar	No. 303 304, 3rd Floor, Hallmark Business Plaza, Sant Dnyaneshwar Marg, Nr.Gurunanak Hospital, Bandra (E), Mumbai - 400051	022-67048603	grievance@systematixgroup.in	Monday - Friday 09:00 AM to 06:00 PM
Compliance Officer	Nipa Savla	No. 303 304, 3rd Floor, Hallmark Business Plaza, Sant Dnyaneshwar Marg, Nr.Gurunanak Hospital, Bandra (E), Mumbai - 400051	022-67048692	compliance@systematixgroup.in	Monday - Friday 09:00 AM to 06:00 PM
Managing Director	Nikhil Khandelwal	The Capital, A-wing, No. 603 – 606, 6th Floor, Plot No. C-70, G Block, Bandra Kurla Complex, Bandra (East), Mumbai – 400051	022-66198123	mddesk@systematixgroup.in	Monday - Friday 09:00 AM to 06:00 PM
In absence of response/complaint not addressed to your satisfaction, you may lodge a complaint with SEBI: SEBI: https://scores.sebi.gov.in Or below exchanges: BSE: https://bsecrs.bseindia.com/ecomplaint/frminvestorHome.aspx NSE: https://investorhelpline.nseindia.com/NICEPLUS/ MCX: https://www.mcxindia.com/Investor-Services/grievances/register-e-complaint NCDEX: https://ncdex.com/grievances CDSL: https://www.cdslindia.com/footer/grievances.aspx NSDL: https://www.epass.nsdl.com/frmLoginPageWebsiteComplaints.aspx Please quote your Service Ticket/Complaint Ref No. while raising your complaint at SEBI SCORES/Exchange portal.

Details of Client Servicing

Contact Person
Kirti Surve

Address
Unit No. 303 & 304, 3rd Floor, Hallmark Business Plaza, Sant Dyaneshwar Marg, Near Gurunanak Hospital, Bandra (East), Mumbai – 400051

Contact No
022-40874075

Email ID
qcsc@systematixgroup.in

Working Hours
Monday - Friday
09:00 AM to 06:00 PM

Details of Head of Client Servicing

Contact Person
Ameya Borkar

Address
The Capital, A-wing, No. 603 – 606, 6th Floor, Plot No. C-70, G Block, Bandra Kurla Complex, Bandra (East), Mumbai – 400051

Contact No
022-66198103

Email ID
grievance@systematixgroup.in

Working Hours
Monday - Friday
09:00 AM to 06:00 PM

Details of Compliance Officer

Contact Person
Nipa Savla

Address
The Capital, A-wing, No. 603 – 606, 6th Floor, Plot No. C-70, G Block, Bandra Kurla Complex, Bandra (East), Mumbai – 400051

Contact No
022-66198092

Email ID
compliance@systematixgroup.in

Working Hours
Monday - Friday
09:00 AM to 06:00 PM

Details of Managing Director

Contact Person
Nikhil Khandelwal

Address
The Capital, A-wing, No. 603 – 606, 6th Floor, Plot No. C-70, G Block, Bandra Kurla Complex, Bandra (East), Mumbai – 400051

Contact No
022-66198023

Email ID
mddesk@systematixgroup.in

Working Hours
Monday - Friday
10:00 AM to 05:00 PM

Advisory for Investors

Beware of fixed / guaranteed / regular returns / capital protection schemes. Brokers or their authorized persons or any of their associates are not authorized to offer fixed/guaranteed/regular returns/ capital protection on your investment or authorized to enter into any loan agreement with you to pay interest on the funds offered by you. Please note that in case of default of a member claim for funds or securities given to the broker under any arrangement/ agreement of indicative return will not be accepted by the relevant Committee of the Exchange as per the approved norms.
Do not keep funds idle with the Stock Broker. Please note that your stock broker has to return the credit balance lying with them, within three working days in case you have not done any transaction within last 30 calendar days. Please note that in case of default of a Member, claim for funds and securities, without any transaction on the exchange will not be accepted by the relevant Committee of the Exchange as per the approved norms.
Check the frequency of accounts settlement opted for. If you have opted for running account, please ensure that your broker settles your account and, in any case, not later than once in 90 days (or 30 days if you have opted for 30 days settlement). In case of declaration of trading member as defaulter, the claims of clients against such defaulter member would be subject to norms for eligibility of claims for compensation from IPF to the clients of the defaulter member. These norms are available on Exchange websites here: a. BSE b. NSE
Brokers are not permitted to accept transfer of securities as margin. Securities offered as margin/ collateral MUST remain in the account of the client and can be pledged to the broker only by way of ‘margin pledge’, created in the Depository system. Clients are not permitted to place any securities with the broker or associate of the broker or authorized person of the broker for any reason. Broker can take securities belonging to clients only for settlement of securities sold by the client.
Always keep your contact details viz. Mobile number/Email ID updated with the stock broker. Email and mobile number is mandatory and you must provide the same to your broker for updation in Exchange records. You must immediately take up the matter with Stock Broker/Exchange if you are not receiving the messages from Exchange/Depositories regularly.
Don't ignore any emails/SMSs received from the Exchange for trades done by you. Verify the same with the Contract notes/Statement of accounts received from your broker and report discrepancy, if any, to your broker in writing immediately and if the Stock Broker does not respond, please take this up with the Exchange/Depositories forthwith.
Check messages sent by Exchanges on a weekly basis regarding funds and securities balances reported by the trading member, compare it with the weekly statement of account sent by broker and immediately raise a concern to the exchange if you notice a discrepancy.
Please do not transfer funds, for the purposes of trading to anyone, including an authorized person or an associate of the broker, other than a SEBI registered Stock broker.

Verification of KYC attributes of clients

We refer to BSE / NSE / CDSL circulars in accordance to which, following 8 KYC attributes are being made mandatory for all categories of investors and investors are required to validate the same even for their existing trading and demat accounts also. Following information needs to be validated by you, so as to ensure that not only all of important details of your accounts are correctly updated across in KYC and you get timely information but also to ensure that you can enjoy seamless and uninterrupted trading and demat transactions with us.
✔ Name ✔ Complete Address ✔ Pin Code ✔ PAN ✔ Category ✔ Mobile Number ✔ Email Id ✔ Income Details
Kindly arrange to get the information verified / updated at the earliest but not later than 31st March, 2022. In case of non-compliance of above, the status of your trading/demat account shall be marked as "closed" by exchanges and debits shall be restricted by depository respectively. Thus no trade and/or debit shall be allowed in such trading or demat account (except for settlement of already open positions). This is as per the directive of the regulator.
To complete your verification / updation process online, please click here.

Securities as Margin by way of Pledge

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w. e. f. September 1, 2020.
Update your mobile number and email id with your stock broker / depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.
Pay 20% upfront margin of the transaction value to trade in cash market segment.
Investors may please refer to the Exchanges' Frequently Asked Questions (FAQs) issued vide NSE circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and BSE notice no. 20200731-7 dated July 31, 2020 and 20200831-45 dated August 31, 2020 and other guidelines issued from time-to-time in this regard.
Check your Securities / Mutual Fund / Bonds in the consolidated account statement issued by NSDL / CDSL.

Advisory - KYC Compliance

All investors are requested to take note that 6 KYC attributes i.e. Name, PAN, Address, Mobile Number, Email id and Income Range have been made mandatory. Investors availing custodian services will be additionally required to update the custodian details.
The last date to update KYC is on or before March 31, 2022.
Thereafter non-compliant trading accounts will be blocked for trading by the Exchange.
The non-compliant demat accounts will be frozen for debits by Depository Participant or Depository.
On submission of the necessary information to the stockbroker and updation of the same by the stockbroker in the Exchange systems and approval by the Exchange, the blocked trading accounts shall be unblocked by the Exchange on T+1 trading day.
The demat account shall be unfreezed once the investor submits the deficient KYC details and the same is captured by the depository participant in the depository system.
To ensure smooth settlement of trades, the investors are requested to ensure that both the trading and demat accounts are compliant with respect to the KYC requirement.
The investors are hereby requested to comply with the regulatory guidelines issued by Exchanges and Depositories from time to time with regard to KYC compliance and related requirements.

..Issued in the interest of investors

Systematix Corporate Services Limited: Merchant Banker SEBI Reg. No. INM000004224 | Systematix Shares and Stocks (India) Limited: BSE SEBI Reg. No.: INZ000171134 (Member Code: 182) | NSE SEBI Reg. No.: INZ000171134 (Member Code: 11327) | MCX SEBI Reg. No. : INZ000171134 (Member Code: 56625) | NCDEX SEBI Reg. No. : INZ000171134 (Member Code: 1281) | Depository Participant SEBI Reg. No.: IN-DP-CDSL-246-2004 (DP Id: 34600) | PMS SEBI Reg. No.: INP000002692 | Research Analyst SEBI Reg. No.: INH200000840 | AMFI Registered Mutual Fund Distributor : ARN – 64917 (Initial registration 21-06-2008 and valid till 20-06-2025) | Systematix Commodities Services Private Limited: NCDEX SEBI Reg No.: INZ000043009 Member Code: NCDEX: 534 | Systematix Fincorp India Limited: NBFC RBI Regn. No. B-10.00160 | Systematix Finvest Private Limited: NBFC RBI Regn. No B-13.00982 | INDIA SME GROWTH FUND: Alternate Investment Fund SEBI Reg. No.: IN/AIF1/18-19/0608 (CAT-I SME) | Systematix Wealth & Assets Services Private Limited : AMFI Registered Mutual Fund Distributor : ARN – 328776 (Initial registration 09-05-2025 and valid till 08-05-2028)

Systematix Corporate Services Limited (CIN: L91990MP1985PLC002969) | Systematix Shares and Stocks (India) Limited (CIN: U65993MH1995PLC268414) | Systematix Commodities Services Private Limited (CIN: U01119MH1994PTC266348) | Systematix Fincorp ( India ) Limited(CIN: U67120RJ1995PLC010601) | Systematix Finvest Private Limited (CIN: U65990MH1995PTC088488) | Systematix Asset Management Company Private Limited (CIN: U65999MH2006PTC266349) | Systematix Capital Services Private Limited (CIN: U67120MH2003PTC266347) Systematix Distribution Services Private Limited (CIN: U51101MH2011PTC225515) | Systematix Ventures Private Limited (CIN: U67190MH2013PTC247782) | Systematix Wealth & Assets Services Private Limited (CIN: U67190MH2013PTC247782)

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2015 certified)

EQUITY

CURRENCY

COMMODITY

IPO

MUTUAL FUND

PMS

SLBM

INVESTMENT BANKING

INSTITUTIONAL EQUITIES

WEALTH MANAGEMENT

DEPOSITORY

PARTNER WITH US

TRADING SIMPLIFIED

PAYMENT GATEWAY

LINK UPI

KYC UPDATION

ReKYC (Document Reactivation/Modification in Account/Nominee Registration/Account Closure)

BANK DETAILS

ACCOUNT OPENING PROCESS

Incapacitated investor

OVERVIEW

EQUITY

DERIVATIVES

IPO

MUTUAL FUND

COMMODITY

CURRENCY

COMPANY INFO

INVESTOR LOGIN

INVESTOR RELATIONS

INVESTOR GRIEVANCES

ODR

SCORES

DOWNLOADS

INVESTOR CHARTER

INFORMATION TO PHYSICAL SHAREHOLDERS

PROCEDURE FOR FILING A COMPLAINT

Investor Education

OUR REACH

CAREERS

Company Snapshot